期刊文献+

胃癌多学科诊断和治疗模式 被引量:1

Multidisciplinary management of gastric cancer
原文传递
导出
摘要 尽管外科手术仍然是胃癌治疗的主要手段,但总体的治疗模式已经发生了明显的改变:从解剖学为基础的手术走向以解剖学、肿瘤生物学及免疫学为基础的手术;从只重视切除肿瘤到以切除原发肿瘤及受侵器官,彻底清除区域淋巴结及杀灭腹腔脱落癌细胞的外科治疗;从单一的手术进入围手术期治疗加规范化手术的新治疗模式. The therapeutic mode has changed over time, although surgery remains the main treatment of choice for gastric cancer. Surgery alone provides long-term survival in only 30% of patients with advanced stages because of the high risk of recurrence and metastasis. Multimodal strategies including neoadjuvant and (or) adjuvant protocols combined with surgery have significantly improved the prognosis of patients with gastric cancer. In particular, perioperative chemotherapy has become the new standard for treatment of patients with advanced gastric cancer. Adjuvant therapy should be carefully discussed after surgical resection, mainly in patients with large lymph node-positive tumors when neoadjuvant therapy can not be carried out. This article reviews the relevant literature on the multidisciplinary management of gastric cancer, and discusses strategies to improve the efficacy of locoregional failures.
作者 季加孚 陕飞
出处 《中华消化外科杂志》 CAS CSCD 2010年第4期241-243,共3页 Chinese Journal of Digestive Surgery
基金 首都医学发展科研基金(2007-2051) 十一五国家科技支撑计划(2006BAI02A06) 国家高技术研究发展专项(2006AA02A402)
关键词 胃肿瘤 多学科 诊断 治疗 Gastric neoplasms Multidisciplinary Diagnosis Therapy
  • 相关文献

参考文献3

二级参考文献13

  • 1Persiani R, D'Ugo D, Rausei S, et al. Prognostic indicators in locally advancd gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy. J Surg Oncol, 2005,89 (4) : 227 - 238.
  • 2日本胃癌学会.胃癌处理规约.13版.东京:金原出版株式会社,1999:38.
  • 3Kim DY, Kim JH, Lee SH. Phase Ⅱ study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer. Ann Oncol, 2003,14 ( 3 ) : 383 - 387.
  • 4Ji JF, Yu Z, Zhong XN, et al. Oxaliplatin-based regimen as neoadjuvant chemotherapy for Chinese patients with advanced gastric cancer: Preliminary results of a phase Ⅱ study. J Clin Oneol, 2004,22(14S) :4184.
  • 5Wohrer SS, Raderer M, Hejna M. Palliative chemotherapy for advanced gastric cancer. Ann Oncol,2004,15 ( 11 ) : 1585 - 1595.
  • 6Allum W, Cunningham D, Weeden S, et al. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: a randomised , controlled trial (the MAGIC trial, ISRCTN 93793971 ). Proc Am Soc Clin Oneol,2005,23 (16S) :4001.
  • 7Satoh S, Hasegawa S, Ozaki N, et al. Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination. Gastric Cancer.2006.9 ( 2 ) : 129 - 135.
  • 8Petrioli R, Pascucci A, Francini E, et al. Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin. Cancer Chemother Pharmaco1,2008,61 ( 1 ) : 105 - 111.
  • 9Cunningham D, Allure WH, Stenning SP, et ah Periopcrative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med,2006,355 ( 1 ) : 11 - 20.
  • 10Boige V, Pignon J, Saint-Aubert B, et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE) : FNLCC ACCORDO7-FFCD 9703 trial. J Clin Oncol,2007,25 (18S) :4510.

共引文献476

同被引文献4

引证文献1

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部